1. No category

07/05/2015
Bedrocan March 2015 Newsletter
A bridge between patients' needs for cannabis and the quality
standards of modern medicine.
Thank you for putting your trust in Bedrocan Canada Inc. BEDROCAN RAMPS UP CANADIAN PRODUCTION
New facility built to produce 4,000 kg of Medical Cannabis per year.
Bedrocan’s newly licensed Canadian facility is ramping up
for domestic production. This past month, Bedrocan
became the first organization to legally import live
genetics (plant clones) of medical cannabis into Canada
from The Netherlands. The clones have settled nicely into their new home, and
are under the careful supervision of our master grow
team. BEDROCAN SPONSORS 2015 CCIC CONFERENCE
The Canadian Consortium for the
Investigation of Cannabinoids
(CCIC) Annual Conference is the
leading professional development
event on cannabinoids in clinical
practice.
The purpose of the Canadian Consortium for the Investigation of Cannabinoids (CCIC) is to
advance our understanding of the role of cannabinoids in health and disease through research
and education. This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance
http://us3.campaign­archive2.com/?u=2c8b1c389b8bcc2e7ed4e19f5&id=351b26de5e&e=eff51974ff
1/5
07/05/2015
Bedrocan March 2015 Newsletter
of Certification Program of The Royal College of
Physicians and Surgeons of Canada, approved by
Continuing Professional Development, Faculty of
Medicine, University of Toronto.
Sponsored Symposium
Bedrocan also sponsored a lunch­time symposium
where Dr. Martin A. Katzman presented on the topic
of “Medical Cannabis: Psychiatry’s New Frontier
Towards Wellness”. Dr. Katzman’s clinical work deals chiefly with the diagnosis
and treatment of mood and anxiety disorders, disorders
with executive dysfunction, disordered cognition and
attentional deficits, as well as chronic pain disorders. In his presentation, Dr. Katzman provided an overview on
the clinical evidence for medical cannabis in the field of
mental health. He also spoke on the importance of
standardization and product consistency. The event was
very well attended by leading physicians from across the
country. Dr. Martin A. Katzman is the Clinic Director of the START
Clinic (Stress, Trauma, Anxiety Rehabilitation and
Treatment) for Mood and Anxiety Disorders. He is a faculty
member of the Northern Ontario School of Medicine (Laurentian and Lakehead University) as
well as the Department of Psychiatry at the University of Toronto. He is also appointed in the
Department of Psychology at Lakehead University and is a member of the Faculty of
Psychology at Adler School of Professional Studies. Dr. Katzman was trained at the University
of Toronto, first undertaking his B.Sc. in Psychology and Neuroscience, and subsequently his
medical training and residency in Psychiatry. He then undertook a research fellowship
examining the psychobiology of mood and anxiety disorders. Click here to listen to a recent radio interview by Dr. Katzman on the topics of Medical
Cannabis, and Mental Health: Radio Interview: Dr Katzman on Talk 770 ­ March­2015
http://us3.campaign­archive2.com/?u=2c8b1c389b8bcc2e7ed4e19f5&id=351b26de5e&e=eff51974ff
2/5
07/05/2015
Bedrocan March 2015 Newsletter
PATIENT ADVISORY BOARD (PAB) INAUGURAL MEETING
The Medical Cannabis Industry's First Patient Advisory Board to Hold Inaugural
Meeting in April 2015 in Toronto.
Bedrocan's Patient Advisory Board (PAB) will be gathering for the first meeting in April 2015.
The group of medical cannabis patients will converge in Toronto for a full­day meeting. There
are four main areas of interest the PAB members have indicated they want to focus on: Feedback ­ providing Patient feedback to Bedrocan
Patient Tools ­ developing Patient education tools
Education ­ enhancing the capabilities of the Patient Advisory Board
Advocacy ­ developing Patient advocacy projects
The PAB will provide a formal venue for patients to provide input to Bedrocan for the purposes
of improving the patient experience, and ensuring that patients are empowered to continue
shaping the medical cannabis landscape. The PAB will be facilitated by Hilary Black, an established patient advocate who brings a wealth
of experience from 18 years of working directly with patients and educating the public,
government and medical community about medical cannabis.
MEDICAL CANNABIS INSURANCE COVERAGE
In The News: Jonathan Zaid Advocates and Wins for Insurance
Coverage of Medical Cannabis
Jonathan Zaid is a patient advocate and founder of Canadians for Fair Access to Medical
Marijuana (CFAMM). Jonathan successfully persuaded his university to include medical
cannabis under his student insurance plan. His recent successes at gaining insurance coverage for medical cannabis have been noticed in
http://us3.campaign­archive2.com/?u=2c8b1c389b8bcc2e7ed4e19f5&id=351b26de5e&e=eff51974ff
3/5
07/05/2015
Bedrocan March 2015 Newsletter
the Canadian press. You can follow Jonathan’s story in the media by checking out a few of the
stories and interviews that have appeared recently in the media:
The Star: http://www.thestar.com/life/health_wellness/2015/03/20/private­insurer­covers­
medical­marijuana­costs.html
CTV News: http://kitchener.ctvnews.ca/insurance­firm­approves­medical­marijuana­coverage­
for­waterloo­student­1.2288316 Ottawa Sun: http://www.ottawasun.com/2015/03/20/ottawa­sun­letters­to­the­editor­march­21
WE WANT TO HEAR FROM YOU
Do you have an idea for a topic or article that you want to see in the
Newsletter?
We would love to hear your suggestions and ideas for the Newsletter. Please email any
suggestions to: [email protected] with the subject: "Newsletter Ideas". How to Reach Bedrocan We love to hear your feedback. You can always send us an email, call us, or visit our Twitter
and Facebook pages to ask questions or send us your comments.
We post our newsletters on our website here: www.bedrocan.ca/newsletter . Thank you for taking the time to read our newsletter. Should you have any questions about
the content of this message, the MMPR program, the medicinal cannabis industry or Bedrocan
http://us3.campaign­archive2.com/?u=2c8b1c389b8bcc2e7ed4e19f5&id=351b26de5e&e=eff51974ff
4/5
07/05/2015
Bedrocan March 2015 Newsletter
Canada, please get in touch with us; we’d like to hear from you!
Bedrocan Canada customer service professionals await your registration, orders and
questions:
In the GTA: 416­943­5800
Outside the GTA (Canada only) Toll­Free: 1­855­420­7887
Email us at: [email protected]
Copyright © 2015 Bedrocan Canada Inc., All rights reserved.
forward to a friend unsubscribe from this list update subscription preferences http://us3.campaign­archive2.com/?u=2c8b1c389b8bcc2e7ed4e19f5&id=351b26de5e&e=eff51974ff
5/5